In lower vertebrates considerable progress has been made in understanding the organization and pharmacology of the spinal networks responsible for rhythmic motor behavior. Glutamate seems to be the major excitatory transmitter in these circuits and is responsible for the excitatory rhythmic drive underlying swimming in the lamprey (for review, see Grillner and Matsushima, 1991) and in the Xenops embryo (Dale and Roberts. 1985; Soffe, 1987) . In both species bath application of the glytine receptor antagonist strychnine can synchronize the normally alternating activity of motoneurons on opposite sides of the animal (Cohen and Harris-Warrick, 1984; Alford and Williams, 1989; Hagevik and McClellan, 1994) . Activation of GABA,\ receptors is not required for left-right alternation during fictive swimming in the lamprey (Grillner and Wallen, 1980; Alford et al., 1991; Tegner et al., 1993; Hagevik and McClellan, 1994 ) but does appear to be involved, together with GABA,, receptors, in the coordination of locomotor activity (Alford et al.. 1991; Tegner et al., 1993) . In higher vertebrates, inhibitory processes also govern the alternation of motoneurons on the right and left side of the animal during locomotion.
In the neonatal rat cord bath application of the GABA, receptor antagonist bicuculline or the glycine antagonist strychnine converts the normal leftright alternation into a synchronous bursting pattern (Harder and Schmidt, 1992) . Much less is known, however, about the pharmacology regulating the alternation of flexor and extensor motoneurons within a limb, since most of the previous work has focused on left/right alternation. Intracellular recordings from cat The Journal of Neuroscience, November 1995, 75(11) 7453 motoneurons during fictive locomotion have revealed the presence of IPSPs that appear to inhibit motoneurons during the activity of their antagonists (Perret, 1983; Pratt and Jordan, 1987) . The pharmacology of these IPSPs has been difficult to address in the intact cat, although there is some evidence that it is glycinergic (Pratt and Jordan, 1987) . Surprisingly little work has been devoted to this issue using in vitro preparations of the spinal cord, although one recent report in the mouse is compatible with glycinergic mediation of the alternation (Droge and Tao, 1993) .
We have been using the isolated lumbosacral spinal cord of the chick embryo to analyze the development of motor activity in a higher vertebrate. This preparation is spontaneously active and produces recurring episodes of rhythmic activity that can be recorded from motoneurons or interneurons (Landmesser and O'Donovan, 1984; 0' Donovan, 1989a; O'Donovan and Ritter, 1995) . Each episode comprises several cycles of activity in which flexor and extensor motoneurons discharge rhythmically. At the beginning of each cycle both sets of motoneurons discharge synchronously. Following this brief synchronous activation flexor motoneurons stop firing at the time of peak extensor activity and then resume firing for the remainder of the cycle. This pattern of activity produces a period of alternation between these antagonist motoneurons during each cycle. As in other species, bath application of excitatory amino acids is a potent activator of rhythmic activity and can convert the episodic pattern of activation into a continuous one (Barry and O'Donovan, 1987) .
Intracellular and whole-cell recordings have identified several types of synaptic input to sartorius and femorotibialis motoneurons, but these inputs have been poorly characterized (O'Donovan, 1989a; Sernagor and O'Donovan, 1991 b) . Of particular interest is the regulation of the sartorius pause in firing, which is accompanied by a large drop in the impedance of sartorius motoneurons and has been attributed to a depolarizing IPSP of unknown pharmacology (O'Donovan, 1989a) . In general, we know very little about the pharmacology of the rhythmic inputs to motoneurons in the developing spinal cord. Earlier pharmacological studies implicated excitatory amino acids in the excitatory drive, but their interpretation was complicated by the observation that spontaneous activity can persist in the presence of NMDA receptor antagonists (Barry and O'Donovan, 1987) . As a consequence, the precise nature of the excitatory drive to lumbosacral motoneurons is unknown. To investigate the pharmacology of the rhythmic inputs to lumbosacral motoneurons we have used local application of antagonists on the ventral surface of the cord or within the motor nucleus in an attempt to restrict their action to the motoneuron synapses. The effect of the drugs was assessed by measuring the discharge patterns of sartorius and femorotibialis motoneurons. Preliminary results of this study have appeared in abstract form (Semagor and 0' Donovan, 1991 a This was indicated by the initiation of motor activity, which happened mainly when the drug was delivered inside the motor nucleus. This problem could be avoided by starting the pressure while the electrode was advanced toward and inside the tissue. In each experiment every drug was generally applied more than once and repeated only when the pattern of recorded activity had returned to that recorded before drug application.
When the drugs were applied onto the surface of the cord recovery was achieved within IO-15 min, after which time the next stimulus or drug would be applied. With ejections inside the tissue, recovery was slightly slower and took 20-25 min at most. Since pressure ejection within the nucleus could result in mechanical effects due to local swelling, we performed controls in which Tyrode's solution without drug was injected into the cord. However, such injections were without significant effects on the nerve activity (see Fig.  3D ).
Qmmtitatirv c1m1y.si.s oj the effects of the drugs OH the pcrttern of motor uctivity.
Quantification of the effects of the different drugs was accomplished by comparing the integral and peak of the averaged rectified neurogram for an averaged cycle (see below and O'Donovan, 1989a) and the duration of the pause in the sartorius neurogram (see Fig. 1 and legend for definitions).
Several cycles were averaged after filtering the recorded neurograms at a bandwidth of 50 Hz to 10 kHz to isolate the spike activity.
The spike activity was then rectified and integrated (time constant, 50 msec), and digitized at I kHz using a commercially available A-D converter (RC electronics) in an AT class personal computer.
In each episode all the cycles that could be clearly discerned were included in the analysis. Sartorius cycles were generally aligned according to the pause onset (Fig. 1A ). Femorotibialis cycles (and sartorius cycles in which the inhibition was pharmacologically blocked)
were aligned according to the initial discharge. A pretrigger time of 400 msec was included for the averaging. As discussed in an earlier report (O'Donovan, 1989a) cycles could not be normalized because certain parameters of the cycle (e.g., the sartorius pause) stay constant, whereas others vary throughout the episode (O'Donovan and Landmesser, 1987; Ho and O'Donovan, 1993) . Therefore, we averaged cycles and allowed the cycle length to vary in accordance with the duration of activity in that cycle. The averaged responses were then imported into a spreadsheet (Quatropro) in order to measure the parameters illustrated in Figure  I . These included: the total amount (or the integral) of activity, the amplitude of the peak discharge (for femorotibialis neurograms) and the duration of the pause (for sartorius neurograms).
All measures were made before and after drug application and during the wash period. Measures are expressed as the mean ? SD. Local application of drugs did not affect the expression of rhythmic activity nor did it substantially alter the temporal structure of the episode (Fig. IC) . This point was important to establish because some of the cycle parameters can vary during the episode. If the episode structure was altered by the drugs, this would affect the selection of cycles used for averaging and could bias the average artifactually. 
Results
To identify the nature of the rhythmic synaptic drive to motoneurons we applied several classes of antagonist locally over motoneurons or within the motor nucleus and monitored the effects on the pattern of discharge recorded from motor nerves. The goal was to block or substantially reduce specific synaptic inputs to motoneurons without disturbing the rhythm.
Thr qjfec.ts of 1ocuIlv applied drugs on the puuse in scrrtoriu.s discharge We found that the pause i n sartorius discharge coul d be abolished by application of bicuculline or picrotoxin over sartorius motoneurons. The pause was shortened by strychnine, by nicotinic, cholinergic antagonists, and by excitatory amino acid antagonists.
Bicwulline und picrotoxin.
Figures 2 and 3A illustrate the effect of bicuculline, a competitive GABA, antagonist, on the inhibition expressed in sartorius motoneurons during motor activity. Figure  2 shows the neurograms obtained, respectively, from the femorotibialis and the sartorius nerves (upper and lower traces in each pair) before (B), during (C), and after (D) the application of the drug on an El0 spinal cord. Bicuculline (I mM) was ejected for 5 set onto the ventral surface of the cord, at the rostra] end of LS2, as shown in the upper diagram (A). In this particular case, the ventral roots of T7 and LS2 were not transected (see Materials and Methods). The pause in the sartorius neurogram was completely abolished in the presence of bicuculline, and the pattern of activity recorded in the sartorius nerve looked similar to that of femorotibialis motoneurons.
Very little change was seen in femorotibialis motoneurons, presumably because the LS3 segment, containing the majority of femorotibialis motoneurons, was not in contact with the drug, which was ejected in the direction of the perfusion stream over LS2. In five El0 cords and one El I cord (total of 52 cycles), bicuculline (I mM or 100 FM), ejected either on the ventral surface of the cord or inside the sartorius nucleus, completely abolished the pause in sartorius activity. In three out of three experiments, intranuclear injection of 100 p,M picrotoxin also abolished the pause in sartorius activity.
Strychnine. In the next set of experiments we investigated the role of glycinergic inhibition in regulating the pause in sartorius activity during each cycle. Pressure ejection of the glycinergic antagonist strychnine (100 FM or I mM) reduced the duration of the pause by 63 ? 22% in six EIO-I I spinal cords (total of When the concentration of strychnine was increased to 10 mM, rhythmic activity was abolished in an irreversible manner and the spikes disappeared. Figure 3B summarizes the effect of strychnine (I RIM) on sartorius motoneurons (average of eight cycles) in the same experiment as in Figure 2 . In this experiment, strychnine depressed the duration of the sartorius inhibition by 32% and recovery was incomplete.
Nicotinic, cholinergic untugonists. We also investigated the effects of local ejections of the nicotinic antagonists curare, mecamylamine, and DHPE on the pause in sartorius firing during motor activity. Curare (100 pM inside the motor nucleus or I mM on the ventral surface of the spinal cord) completely blocked the pause (measured in 23 cycles) in three El0 preparations and shortened it by 80% in one El I embryo. Figure 3C illustrates an example of the effect of curare ejected on LSI in one of those spinal cords (1 mM for 5 set).
Since curare can antagonize GABA agonists in spinal motoneurons (Perrins and Roberts, 1994) it is possible that its effect on the pause might be due, in part, to blockade of GABA, receptors. For this reason we used two other cholinergic antagonists, mecamylamine and DHPE, to establish if there is a cholinergic component to the pause. In developing Xenopus motoneurons mecamylamine does not antagonize the effects of the GABA, agonist muscimol, whereas curare does (Perrins and Roberts, 1994) . In the present work, we found that both drugs (mecamylamine and DHPE) depressed the pause in sartorius discharge, although it was not abolished (Fig. 4) . Mecamylamine reduced the duration of the pause by 62 2 9% (34 cycles in four embryos). DHPE decreased the pause duration by 74 ? 13% (48 cycles in four embryos; see Fig. 4 ). For most trials, both drugs were used at a concentration of 100 pM and injected into LS I, although one application of both drugs was made onto the ventral surface of LSI at a concentration of I mM.
Nipecotic mid: A GABA uptuke inhibitor. To provide additional evidence for the participation of GABA, receptor involvement in the sartorius pause we examined the effects of nipecotic acid, a GABA uptake inhibitor on the pattern of sartorius discharge. Figure 5 illustrates the effect of nipecotic acid injected inside LS I in an E I I spinal cord ( 10 mM for 30 set). Figure 5A shows the neurograms of sartorius (S) and femorotibialis (F) before, during, and after the drug injection. The upper three traces in Figure 5B represent 17 averaged, rectified, and integrated cycles of sartorius activity from the same experiment illustrated in part A of Figure 5 and show that blockade of GABA uptake depresses sartorius discharge. Bath application of nipecotic acid (n = 4, I mM) produced similar effects to the intranuclear injection, and resulted in the abolition of sartorius discharge and a depression of the slow potentials recorded from the muscle nerve.
Because nipecotic acid increases the amount of GABA near GABA release sites, it is reasonable to assume that bicuculline, which competes with the endogenous neurotransmitter for receptor occupancy, will be less effective in the presence of nipecotic acid. We found that this was true, as is illustrated in Figure 5B , middle and lower traces. Bicuculline, which at a concentration of 100 FM reduced the inhibition by 64% (in five cycles) when injected inside the motor nucleus in this preparation, had no effect when injected together with nipecotic acid IO mM (Fig. 5B, middle traces, seven cycles) . Under these conditions, the sartorius discharge was almost abolished. However, when the concentration of the antagonist was increased IO-fold, The effects of locally applied mecamylamine and DHPE on the pause in sartorius tiring. Each trace is a neurogram recorded from the sartorius (SART) or femorotibialis (F/34) muscle nerves before (A and D, Conrrol), duiing (B and E, Dnrg.s), and after (C and F. Wdw~;t) local application of cholinergic antagonists. In the drug recordings, the location of the pause is indicated by the OI'TOII'S. Both drugs were injected into LSI 20 set before rhythmic activity was initiated by ;I stimulus to the cord.
The recordings were made i n a spi nal cord from an E IO embryo. the inhibition was completely abolished both in the presence of the antagonist alone (in eight cycles) and in the presence of the antagonist together with nipecotic acid (Fig. SB, lower traces, four cycles) in a similar manner to the experiment illustrated in Figure 2 .
The fact that bicuculline can antagonize the actions of nipecotic acid suggests that the actions of nipecotic acid on the pattern of motor discharge are due to a prolonged action of GABA on GABA, receptors rather than on other GABA receptor subtypes.
As illustrated in Figure 5 , nipecotic acid injected into LSI appeared also to influence the pattern of femorotibialis discharge. This effect could be due to spread of the drug onto femorotibialis motoneurons because femorotibialis discharge was affected in a similar manner when the drug was bath applied. Alternatively, the drug may have spread to affect presynaptic interneurons common to both sets of motoneurons.
Taken together, the results of puffing antagonists onto sartorius motoneurons favor the hypothesis that the pause in sartorius discharge is due primarily to the action of synaptically released GABA on GABA, receptors. All of the other antagonists we studied were not as effective as bicuculline or picrotoxin at depressing the pause in sartorius discharge. The observation that several antagonists including strychnine, cholinergic antagonists, Figure 5 . Inhibition of GABA uptake in the presence of nipecotic acid depresses discharge recorded from the sartorius nerve. A illustrates the effect of nipecotic acid (10 mM, injected inside LSI for 30 set, El1 spinal cord) on the nerve (sat-t, sartorius; ,frm, femorotibialis) discharges. The mo qper recordings are the control, the hvo middle recordings were obtained in the presence of nipecotic acid, and the mo louver recordiqs show the recovery from this GABA uptake inhibitor. These recordings represent entire episodes of activity. B shows how nipecotic acid, which enhances the effects of GABA, competes with bicuculline, which blocks the effects of GABA. These traces are rectified, integrated averaged cycles obtained from the same preparation as in A. The middle ~m,er truce (c/rug) shows the enhancing effect of nipecotic acid (10 mM) on the sartorius inhibition (average from seven cycles). The middle truce on the second row shows how bicuculline (100 mM) lacks any effect on sartorius discharge when applied together with nipecotic acid (10 mM; average from seven cycles). However, the effect of bicuculline was recovered when the concentration of the drug was increased lofold without changing the nipecotic acid concentration, as illustrated in the middle pnel of the third MIV (average from four cycles). and excitatory amino acid antagonists (see below) reduced the pause in sartorius discharge suggests that other input systems are involved in addition to GABAergic inputs (see Discussion).
The qfects of Iocully upplied inhibitory antugonists on ,femorotihiulis discharge Local application of bicuculline (100 FM inside LS3 or 1 mM over the ventral surface, n = 5 experiments) decreased the duration of the femorotibialis discharge, reduced the integrated activity, and increased in the peak discharge (Fig. 6A,C) . Bicuculline (1 mM, ejected on the ventral side of the cord) increased the peak femorotibialis discharge by 40 % 14% while reducing
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Control BIC 4 set Wash 1 set Figure 6 . The effects of local application of inhibitory antagonists on the firing and slow potentials recorded from the femorotibialis muscle nerve. A, The effects of bicuculline (BIG, 100 PM) applied inside LS2-3 20 set before the onset of evoked rhythmic motor activity. The dashed l i ne in each record shows the baseline for the slow potentials. R. Local application of strychnine (STR, 100 FM) inside LS2-3 has less effect than bicuculline on the discharge and slow potential activity. Recordings in A and B were made from the same El 1 embryo. C. Recordings from a different embryo of the rectified averaged femorotibialis neurogram in control Tyrode's, following local application of I mM hicuculline onto LS3 (BIG) and after washout of the drug.
the integrated discharge by 20 + 9% (13 cycles measured in two preparations). The profile of the slow potentials recorded from the femorotibialis muscle nerve was also altered following application of bicuculline (Fig. 6A, BIC) . The antagonist increased the peak amplitude of these potentials in each cycle and reduced the level of the depolarization between cycles. Locally applied strychnine (100 FM inside LS3) had little effect on either the pattern of discharge or the slow potentials recorded from the muscle nerve (Fig. 6B) .
The action of GABA on spinul neurons und the spec(jicity of inhibitory antugonists
Because our experiments suggested a primary role for GABA in the pause of sartorius discharge, we investigated the effects of GABA application on the membrane potential and conductance of spinal neurons. Earlier work using intracellular or whole-cell recording from identified sartorius motoneurons had were done in Tyrode's solution in which no calcium had been added. DC current was injected to hold the membrane potential of the cell at different levels, and then GABA (100 PM) was pressure ejected adjacent to the recording site. Short, hyperpolarizing pulses were administered continuously. Notice the decrease in conductance that accompanies the GABA-induced depolarization. B, Plot of the amplitude of the GABA-induced membrane potential change (GABA resp:ponse) against the holding potential (me&rune potrnriol) in a different cell from that shown in A during application of 100 )LM GABA.
revealed the pause was accompanied by a depolarizing synaptic potential and a large increase in membrane conductance (0 ' Donovan, 1989a; Sernagor and 0' Donovan, 199 I a; O'Donovan et al., 1992) . Although GABA is known to produce depolarizing responses in developing rat motoneurons when recorded with sharp electrodes (Wu et al., 1992) , its effects on motoneurons in the isolated chick spinal cord have not been documented. Our experiments allowed us to establish the specificity of the inhibitory antagonists bicuculline and strychnine on the membrane potential changes produced by GABA and to examine the conductance changes accompanying GABA application.
Whole-cell patch recordings were made from ventrally located neurons in transverse slices of spinal cord one to two segments thick. Recordings were made in the presence of I FM TTX or in zero Ca?' Tyrode's solution to block synaptic transmission. GABA (I 00 FM) pressure ejected close to the slice surface resulted in a depolarization in 21 out of 23 recorded cells (Fig.  7A) . The amplitude of this depolarization at rest ranged between 5 and I5 mV. Injection of short (20 msec) hyperpolarizing pulses during the GABA-induced depolarization revealed a decrease in membrane resistance. In the cell illustrated in Figure 7 , the membrane resistance decreased by 7.5% during the application of GABA. Both the depolarization and the impedance change were blocked by bicuculline (n = I I) but not by strychnine (II = 4). The reversal potential for this GABA-induced response was determined under current clamp by injecting depolarizing DC current and puffing on GABA at different holding potentials. The reversal potential averaged -45 ? I7 mV (n = 8 cells, see Fig.  7B ), which is substantially more positive than the expected reversal potential for chloride (see Discussion), although there was considerable variation between neurons (range -I6 to -64 mV). The variability may have been due to a number of factors, including distance from the recording to the site of the GABA application, fidelity of the clamp, or incomplete dialysis of the intracellular contents. Despite this variability, it is clear that at the developmental stages examined here, a large proportion of ventrally located neurons depolarize when exposed to GABA, and that this response displays a pharmacology characteristic of GABA, receptors. These findings were confirmed by experiments in which the GABA-induced depolarization was recorded in the ventral roots of the isolated cord instead of intracellularly from slices. The ventral root potential was blocked reversibly by bicuculline (n = 6) or by picrotoxin (n = 3), but not by strychnine (n = 4; each antagonist was used at a bath concentration of 100 PM).
These findings are consistent for a role for GABA in regulating the pause in sartorius discharge. Furthermore, they indicate that the reduction of the pause caused by strychnine is unlikely to be due to a lack of specificity for this inhibitory antagonist.
The effects qf bath-applied inhibitory antu~onists on the pattern oJ'jexor and extensor activif? To obtain further evidence for the role of inhibitory amino acids in the patterning of flexor and extensor activity we bath applied glycine and GABA, antagonists and determined their effects on rhythmic motor activity, in particular, on the patterning of sartorius and femorotibialis discharge. We hypothesized that if GABA, or glycine receptors were the major determinants of the sartorius pause, then it should be abolished in the presence of the bath-applied antagonists. However, this was not the case. In the presence of bicuculline (50 FM, n = 6/6) we found that the pause in sartorius was still present and, in addition, a pause was induced in the firing of femorotibialis motoneurons. The induction of a pause in femorotibialis motoneurons was age dependent and was not observed in embryos younger than EIO. In El I and El2 embryos, bath application of 5-10 p,M bicuculline resulted in the appearance of a small pause in the femorotibialis discharge (Fig. 8B, arrows) . At this concentration, the pause was mainly induced in those cycles at the end of an episode. As the bath concentration of bicuculline was increased, the duration of the pause in femorotibialis discharge increased in a dose-dependent manner (Fig. 8%E ) and the profile of the femorotibialis discharge was altered. In control recordings, the femorotibialis burst declines throughout the cycle in contrast to the sartorius discharge, which augments after the pause. At 20, 30, and 50 FM, the femorotibialis discharge exhibited a similar profile to that of sartorius (Fig. SC,D) .
Strychnine had the same effect as bicuculline, provided that the extracellular concentration of K+ was elevated from 3 mM to 6 mM (Fig. 9B) . Elevation of the extracellular concentration of K' was necessary because strychnine depressed the number of cycles in an episode in normal Tyrode's, and this effect could be corrected by increasing the concentration of extracellular K+. and altered the profile of the femorotibialis discharge from a decreasing protile to a recruiting profile characteristic of sartorius discharge.
E. Dose dependency of the average pause duration (+ SD) in sartoriui and femorotibialis motoneurons measured in an El 1 embryo. The neurograms were filtered between 100 Hz and 3 kHz.
In the presence of both inhibitory antagonists the pause in the discharge of both sartorius and femorotibialis motoneurons was preserved (Fig. 9C) .
As would be predicted, local application of bicuculline had no effect on the pause in sartorius discharge in the presence of bath-applied bicuculline and strychnine, in contrast to its action in normal Tyrode's solution. However, local application of the NMDA-receptor antagonist AP-5 over sartorius motoneurons (0.3-0.5 mM, 20 set, n = 7) or femorotibialis motoneurons (0.3-0.5 mM, 20 set, n = 4) reversibly abolished the pause in firing recorded from either nerve (Fig. 9D) . In control recordings made in the normal Tyrode's solution, local application of AP-5 (0.5 mM) reduced the sartorius pause only slightly (by 24 ? 13%, IZ = 4 embryos, 54 cycles, see below).
These findings suggested that glutamatergic inputs might be capable of suppressing sartorius and femorotibialis discharge in the disinhibited cord. The effects of excitatory umino acid untagorG.sts on the putter-n qf mntoneuron discharge Glutamate plays a major role in the excitatory locomotor synaptic drive in several to species. In the chick cord, preliminary experiments have estimated the reversal potential for the rhythmic synaptic drive to femorotibialis motoneurons to be close to 0 mV (O'Donovan et al., 1992; Sernagor and O'Donovan, 1990, 199 1 b) consistent with the action of glutamatergic synapses. The excitatory drive to sartorius motoneurons has not been well characterized. To investigate the pharmacology of the excitatory synaptic drive to flexor and extensor motoneurons we applied antagonists of excitatory amino acids in a similar manner to the inhibitory antagonists.
Femorotibialis. NMDA, non-NMDA, and glutamate receptor antagonists all reduced the amount of activity expressed in femorotibialis motoneurons. Figure IOA shows the effect of intranuclear injection of kynurenate (IO mM, middle record), a "broad spectrum" competitive glutamate antagonist and AP-5 (IO mM, Fig. IO& middle record) , a specific competitive NMDA receptor antagonist on femorotibialis nerve activity in an El0 spinal cord. Both kynurenate (5-10 mM, n = 5 experiments) and n = 6 experiments) depressed the integrated femorotibialis nerve activity, respectively, by 84 + 2% (measured in 31 cycles from two experiments with intranuclear injection) and 45 i 20% (47 cycles measured in three experiments; two with ejections on the ventral surface and one with injection inside the nucleus). The femorotibialis discharge was also depressed by 2,4-dihydroxyphenylacetic acid (2,4DHPAA), a specific competitive glutamate antagonist (l-10 tIIM, II = 3), and CNQX, an ampa/kainate antagonist (0.05 mM, II = 3). All these antagonists had to be used at a high concentration in order to produce depression of discharge and were most effective when injected inside the nucleus. Although the concentration of these antagonists was high, it is important to emphasize that the effective tissue concentration of the drugs will be lower as they diffuse from the injection site.
Surtorius.
Analysis of the excitatory drive to sartorius motoneurons was complicated by the fact that excitatory amino acids antagonists delivered to the sartorius nucleus affect the inhibitory component of the response. As a result, it was difficult to isolate and quantify specific actions on the excitation. Figure 11 illustrates the actions of several excitatory amino acid antagonists applied within the motor nucleus on the discharge of sartorius motoneurons. The NMDA receptor antagonist AP-5 (0.5 mM injected inside LS I) had the least effect on the sartorius discharge pattern. Following application of this drug, the pause in firing was reduced by 24 2 13% (four embryos, 54 cycles). CNQX, an antagonist at ampa/kainate receptors, shortened and could abolish the pause in sartorius firing (average decrease in duration 61 t 1 I%, three embryos, 88 cycles). Kynurenate (0.5 ITIM, n = 3 embryos) was the most effective antagonist and reduced the sartorius pause by 93 ? 6%, three embryos, 117 cycles). At 500 p.M, kynurenate did not depress sartorius discharge significantly (Fig. 1 lF) , but in three out of four experiments, firing was depressed using kynurenate at a higher concentration (10 mM).
Discussion
This work has investigated the pharmacology of the synaptic drive onto flexor and extensor motoneurons during rhythmic motor activity in the developing spinal cord of the chick embryo. The results demonstrate that the timing of flexor and extensor activity is regulated predominantly by a GABAergic inhibitory mechanism although nicotinic, cholinergic. glycinergic, and even glutamatergic inputs can contribute to the pause in sartorius discharge. Under conditions of disinhibition produced by blockade with inhibitory amino acids, glutamatergic inputs appear to be the dominant regulator of the pause in sartorius discharge (see below).
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The pause in sartorius discharge was blocked by locally applied bicuculline or picrotoxin, implicating a primary role for GABA on GABA, receptors. Although curare mimicked the actions of bicuculline, its effects may be complicated by an action on GABA receptors. Curare has been reported to antagonize the effects of GABA or its agonists at GABA, receptors on developing neurons in spinal cord (Bixby and Spitzer, 1982; Perrins and Roberts, 1994) and hippocampus (Siebler et al., 1988) . Additional evidence in favor of GABAergic mechanisms comes from the demonstration that the GABA uptake inhibitor nipecotic acid could block the sartorius discharge and depress the slow potentials recorded from the muscle nerve. This action is compatible with a prolonged action of endogenously released GABA at active terminals.
The conclusion that synaptically released GABA acting on GABA, receptors is a major determinant of the pause is consistent with the actions of GABA puffed onto spinal neurons. Exogenously applied GABA depolarizes spinal neurons and produces a signilicant increase in membrane conductance. Both of these properties have been shown to characterize the synaptic potential in sartorius motoneurons that accompanies their pause in tiring (O'Donovan, 1989a; Sernagor and O'Donovan, 1991; O'Donovan et al., 1992) . However, because we used whole-cell patch recording to monitor the GABA-induced effects, the intracellular chloride concentration should be dictated by the concentration of chloride in the electrode-assuming complete dialysis of the intracellular contents. Under this assumption the chloride reversal potential would be determined by the chloride concentration of the electrode contents and the Tyrode's solution, and would be greater than -100 mV for the solutions used in the present work. Nevertheless, we found that the reversal potential for the GABA-induced depolarizations averaged -45 mV, signilicantly more positive than the calculated chloride reversal potential. At present, we cannot account for this discrepancy. Possible explanations are that the intracellular chloride concentration is not determined exclusively by the electrode contents or, alternatively, that ions other than chloride contribute to the GABA-induced depolarizations. Resolution of this issue will require analysis of the ionic dependence of the GABAinduced responses.
Our findings can be used to explain the altered pattern of firing in sartorius motoneurons when the pause is abolished by bicuculline or picrotoxin. In normal Tyrode's solution the depolarizing GABAergic drive summates with the excitatory drive to sartorius motoneurons, producing a shunt at the peak depolarization (Fig. 12A) . As the drive and shunt decay, the sartorius firing resumes. When GABA, receptors are blocked, the depolarization and the shunt are reduced, which shortens the duration of the discharge and advances it in the cycle. In this way, the discharge of sartorius now closely resembles that of femorotibialis motoneurons (Fig. 12B) .
Another possibility to account for the effects of bicuculline on the sartorius pause is that the antagonist blocks presynaptic inhibition (Stuart and Redman, 1992) . However, we consider this an unlikely explanation because the pause persisted in the presence of bath-applied bicuculline. Furthermore, the pause was reduced by excitatory and cholinergic antagonists, which cannot be explained by an action on classical GABAergic presynaptic inhibitory mechanisms. It is also possible that synaptically released GABA might act also on GABA, receptors, although such an effect should not be antagonized by bicuculline. Further experiments will be required to establish if GABA,, receptors play any role in the sartorius inhibition. Although GABA, receptor antagonists produced the most complete blockage of the pause, several other antagonists reduced its duration. In particular, strychnine and the nicotinic, cholinergic antagonists mecamylamine and DHBE both depressed the pause in firing. It is unlikely that the effects of strychnine are due to an action on GABA, receptors because 100 pM strychnine did not antagonize the effects of GABA applied to spinal neurons. In addition, previous studies have reported that strychnine and bicuculline specifically antagonize glycine and GABA, respectively, in neonatal rat spinal neurons (Wu et al., 1992) and in cultured chick spinal neurons (Obata et al., 1978) . We did not test the ability of mecamylamine and DHBE to antagonize locally applied GABA in the chick spinal cord. However, mecamylamine does not antagonize the actions of muscimol, a GABA, agonist, on spinal motoneurons in Xennpls embryos, even though curare does (Perrins and Roberts, 1994) .
The effects of the cholinergic antagonists mecamylamine and DHBE could be explained by postulating a cholinergic pathway parallel to, or in series with, the inhibitory pathways. One possible pathway with the latter pharmacology is the recurrent inhibitory circuit, which is depressed by cholinergic and inhibitory antagonists (Velumian, 1984; O'Donovan 1989b) . The participation of recurrent inhibition is plausible because the onset of each cycle of activity in sartorius can be associated with a prominent discharge, which is synchronized in several motoneuron pools (Landmesser and O'Donovan, 1984; O'Donovan, I989a) . Furthermore, the cholinergic motoneuron axon collaterals are likely to be located close to the lateral motor column where they should be susceptible to the action of locally applied antagonists. It is also possible that the cholinergic antagonists might act on receptors located on motoneurons rather than on interneurons. Finally, the nicotinic antagonists could act on nicotinic. presynaptic receptors on the inhibitory GABAergic terminals projecting to motoneurons. In several systems, including the embryonic chick brain (McMahon et al., 1994) presynaptic nicotinic receptors have been shown to facilitate GABA release (Wonnacott et al., 1989) , so that their blockade might reduce release.
The pause in sartorius discharge was also depressed by the excitatory amino acid antagonist kynurenate and the ampa/kainate receptor antagonist CNQX, and to a lesser degree by the NMDAreceptor antagonist AP-5. The effects of the excitatory amino acid antagonists could be explained by postulating blockade of inhibitory intemeurons or alternatively by blockade of receptors on the motoneuron membrane. An action on intemeurons is plausible because the drug injections inside the nucleus are probably not limited to motoneurons and a region critical for the pause has been shown to be located just dorsomedial to the lateral motor column (Ho and O'Donovan, 1993) . However, an action on inhibitory intemeurons cannot account for the ability of the NMDA-receptor antagonist AP-5 to block the pause in sartorius and femorotibialis discharge in cords in which inhibition was blocked by bicuculline and strychnine.
An alternative explanation is that the antagonists are blocking receptors on the motoneuron membrane. We hypothesize that in the disinhibited cord there is an increase in the number of functionally active glutamate receptors on the soma and dendrites of both sartorius and femorotibialis motoneurons (see Fig. 12C ). (-) .
In the right panrls are the activity patterns under the different conditions.
The upper trace in each record is the slow potential recorded from the sartorius muscle nerve, which acts as a reference for each cycle. The lower fwo truces in each of the right punels show the filtered discharge of the sartorius and femorotibialis muscle nerves. The cwrows mark the peak of the slow depolarization in each panel, which coincides with the peak depolarization in the both sets of motoneurons.
A, Synaptic connections and activity patterns in normal Tyrode's solution. In this and the other figures we have presented the cholinergic connections as part of the recurrent inhibitory pathway.
However, the cholinergic connections could be directly onto the motoneurons. For simplicity, we have not illustrated glycinergic inputs to the motoneurons or the GABAergic input to femorotibialis motoneurons (see text for details). B. Connections and activity during local application of bicuculline over sartorius motoneurons, which abolishes the pause in the discharge of sartorius motoneurons.
C, Connections and activity during bath application of bicuculline, which induces a pause in femorotibialis activity. (Fig. 12C) . The idea that synaptically released glutamate might be functionally inhibitory will require careful confirmation in future experiments by examining the effects of direct application of glutamate or its agonists onto discharging motoneurons.
Excitutoty drive to sartorius und femorotibialis motoneurons
The discharge of sartorius and femorotibialis motoneurons was depressed by several classes of excitatory amino acid antagonists. The drugs had to be used at higher concentration than the antagonists affecting the pause and never resulted in a complete suppression of firing. This presumably occurred because the ex-'ER SAR ac FEM --ac citatory inputs are located on dendrites rather than on the soma. Because the drugs had to be injected at high concentration into the nucleus, it is likely that they will have spread to affect interneurons. Thus, the results of excitatory blockade may be a combination of direct effects on motoneuron excitatory amino acid receptors and excitatory inputs to interneurons.
A major role of excitatory amino acid involvement in the excitatory drive to motoneurons is consistent with whole-cell recordings of the rhythmic excitatory synaptic drive in femorotibialis motoneurons, which has an equilibrium potential near 0 mV (Sernagor and O'Donovan, 1990, 1991 b; O'Donovan et al., 1992) .
Inhibitory drive to femorotibialis moto?leurons Local application of bicuculline resulted in an increase in the peak discharge of femorotibialis motoneurons and a reduction
